Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.80 +0.28 (+3.35%)
As of: Nov 11, 2026 · 3:59 PM EST

Aspire-Lakewood Holdings (ASBP) EBIT Margin (2025 - 2026)

Updated

Aspire Biopharma Holdings' EBIT Margin came in at -4244.14% for Q2 2026, up 1561.84 percentage points from the prior quarter.

Analysis

Aspire-Lakewood Holdings (ASBP) EBIT Margin (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Aspire Biopharma Holdings reported EBIT Margin of -7494.76%; for FY2025, it was -312016.95%.

  • Business Quant data shows ASBP's EBIT Margin at -5805.98% (Q1 2026), -43403.52% (Q4 2025) and -59015.82% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Aspire-Lakewood Holdings 63.98 Mn 43.01 Mn -30,086.00 -4,244.14%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,244.14%
Mar 31, 2026 -5,805.98%
Dec 31, 2025 -43,403.52%
Sep 30, 2025 -59,015.82%
API Access

Aspire-Lakewood Holdings EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ASBP&period=max&api_key=YOUR_API_KEY